GSK: Momelotinib Granted Orphan Drug Designations In The US, EU

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) – GSK plc (GSK, GSK.L) announced that momelotinib has received Orphan Drug Designation from the FDA and European Medicines Agency for the treatment of VEXAS synd…